Mercy Vascular Surgeon Dr. Paul Lucas Performs New Drug-Coated Balloon Angioplasty to Treat PAD on Patient in Maryland

October 30, 2014
The Vascular Center at Mercy

Mercy vascular surgeon Dr. Paul Lucas performed a new angioplasty treatment for peripheral artery disease, using a tiny drug-coated balloon that reopens clogged arteries. The patient is the first in Maryland to undergo the procedure, notes Dr. Lucas, Director of the nationally accredited Vascular Laboratory at The Vascular Center at Mercy and a Registered Physician in Vascular Interpretation.

Millions of Americans suffer from peripheral artery disease, which causes fatty material to build up in the arteries carrying blood to the head, organs and limbs. If untreated, the disease can lead to severe blockage in the arteries of the legs or feet, and even amputation.

The Lutonix 035 Drug Coated Balloon PTA Catheter allows medication to be released onto the inner surface of the artery to limit the amount of scarring that occurs following the procedure.

Limiting scarring extends by several years the amount of time before the artery may become blocked again. The standard treatment lasts one to two years; this new one, three to five years.

In typical angioplasty, a doctor threads a thin tube through a blood vessel in the arm or groin up to the blockage, then inflates a tiny balloon at the end of the tube to push the plaque outward against the wall of the artery. This widens the artery and restores blood flow. The new treatment adding a low-dose coating of Paclitaxel to the balloon was recently approved by the U.S. Food and Drug Administration.

Paclitaxel is also used in cancer chemotherapy. The medication, when used in arteries, kills the cells that are responsible for creating scarring, Dr. Lucas explained.

An experienced vascular surgeon with The Vascular Center at Mercy in Baltimore, Dr. Lucas is Board Certified in General and Vascular Surgery. He  specializes in the diagnosis and treatment of patients with diseased blood vessels.


Dan Collins - Senior Director of Media Relations at Mercy Medical Center

Dan Collins, Senior Director of Media Relations

Email: dcollins@mdmercy.com Office: 410-332-9714 Cell: 410-375-7342

About Mercy

Founded in 1874 in downtown Baltimore by the Sisters of Mercy, Mercy Medical Center is a 183-licensed bed acute care university-affiliated teaching hospital. Mercy has been recognized as a top Maryland hospital by U.S. News & World Report; a Top 100 hospital for Women’s Health & Orthopedics by Healthgrades; is currently A-rated for Hospital Safety (Leapfrog Group), and is recognized by the American Nurses Credentialing Center as a Magnet Hospital. Mercy Medical Center is part of Mercy Health Services (MHS), the parent of Mercy’s primary care and specialty care physician enterprise, known as Mercy Personal Physicians, which employs more than 200 providers with locations in Baltimore, Lutherville, Overlea, Glen Burnie, Columbia and Reisterstown. For more information about Mercy, visit www.mdmercy.com, MDMercyMedia on FacebookTwitter, or call 1-800-MD-Mercy.

News and Events